MAI Capital Management’s VanEck Biotech ETF BBH Stock Holding History

MAI Capital Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-265	Closed	-$49.8K	–	2334
2026 Q1	$49.8K	Hold	265	–	–	﹤0.01%	2222
2025 Q4	$50.2K	Hold	265	–	–	﹤0.01%	2007
2025 Q3	$43.9K	Hold	265	–	–	﹤0.01%	2009
2025 Q2	$40.6K	Hold	265	–	–	﹤0.01%	1979
2025 Q1	$41.7K	Hold	265	–	–	﹤0.01%	1839
2024 Q4	$41.6K	Buy	+265	New	+$44.6K	﹤0.01%	1868

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAI Capital Management's BBH Position: Q2 2026 in Review

MAI Capital Management sold out of VanEck Biotech ETF (BBH) in Q2 2026, closing a stake of 265 shares — an estimated $49.8K sold.

MAI Capital Management first reported a position in BBH in Q4 2024 and held it in 6 quarters. The position peaked at $50.2K in Q4 2025. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

MAI Capital Management reported no remaining VanEck Biotech ETF position as of Q2 2026 after selling out during the quarter.
MAI Capital Management sold 265 VanEck Biotech ETF shares in Q2 2026, an estimated $49.8K.
MAI Capital Management first reported a position in VanEck Biotech ETF in Q4 2024 and held it in 6 quarters.
MAI Capital Management's VanEck Biotech ETF position peaked at $50.2K in Q4 2025.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.